2024 annual financial data
Gyre Therapeutics 2024 Operating margin
Direct answer
Operating margin was 15.35%.
Operating income was 16,229,000 USD and net income was 12,085,000 USD.
Operating cash flow was -3,641,000 USD.
Get free Gyre Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 105,757,000 USD
- Operating income
- 16,229,000 USD
- Net income
- 12,085,000 USD
- Operating cash flow
- -3,641,000 USD